Humana (HUM ) Tops Q2 EPS by 4c, Reaffirms FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Humana Reports Second Quarter 2015 Financial Results; Reaffirms 2015 Financial Guidance
July 29, 2015 7:30 AM EDT2Q 2015 EPS of $2.85 includes $1.18 of gain related to sale of Concentra 2Q 2015 Adjusted EPS of $1.67 excludes the Concentra 2Q 2015 gain and compares to managements guidance of $1.60 to $1.65 Reaffirmed full-year 2015 EPS guidance of approximately $9.28 or $7.75 on an Adjusted basis (excluding the year-to-date gain on sale of Concentra of $1.53 per share) 2Q 2015 Medicare Advantage utilization seen as stabilizing and tracking with managements revised expectations Actions taken to improve profitability of individual commercial and state-based contracts businesses
... More
